Prenatal gene manipulation starts to affect health care around 2020
Grader A: miss
Grader B: partial
disagrees with A
Third agent: partial
settled the disagreement (D20)
Published: partial
Grader A: miss
The only known case, He Jiankui's CRISPR-edited twins (2018), was condemned and criminally punished (3-year sentence, Dec 2019); heritable editing remains prohibited. No clinical use by 2025; the practice was effectively abandoned.
Test: D37 health: share of relevant patients, providers or procedures using it by 2022 (hit >=5%; partial <5% real use by 2022 or 5% in 2023-2025; miss no real use by 2025); relevant: pregnancies/IVF cycles
Grader B: partial
CRISPR embryo editing produced three babies in China (2018) and was criminalised, so that path is abandoned. But licensed mitochondrial donation (pronuclear transfer, a germline modification of the embryo) runs as an NHS clinical service in Newcastle (licensed 2017), with eight babies reported in July 2025. Real, licensed, tiny-scale use inside the window = partial. A strict 'nuclear gene editing' reading would give miss.
Test: D37 health: >=5% of relevant IVF/prenatal cases by 2022 = hit; real clinical use below 5% (licensed niche service) = partial; no real use by 2025 or abandoned = miss.